Hybrid Membrane Nanovaccines Combined with Immune Checkpoint Blockade to Enhance Cancer Immunotherapy.
Peiqi ZhaoYuanlin XuWei JiLanfang LiLihua QiuShiyong ZhouZhengzi QianHuilai ZhangPublished in: International journal of nanomedicine (2022)
These findings suggest that the hybrid membrane nanovaccine in combination with immune checkpoint blockade is a powerful strategy to enhance antitumor immunotherapy without concerns of systemic toxicity.
Keyphrases